Cubist Pharmaceutical’s (CBST) Stock of the Day
Feb 12th, 2009 | By Matt Weinschenk | Category: FeaturedInvestment in Cubist (CBST) has now become a twofold offer. If the company defends its patent position against Teva Pharmaceutical Industries Ltd (TEVA) who produces the low-cost generic version of the drug Cubicin, shares will surge. If Teva wins the fight, Cubist is likely a penny stock.